Sharon Barbari
Director/Board Member chez AGILE THERAPEUTICS, INC.
Fortune : 3 527 $ au 31/03/2024
Profil
Sharon Barbari currently works at Agile Therapeutics, Inc., as Independent Director from 2020 and VYNE Therapeutics, Inc., as Independent Director from 2020.
Ms. Barbari also formerly worked at Sonoma Pharmaceuticals, Inc., as Independent Director from 2014 to 2021, VYNE Pharmaceuticals Ltd., as Director, Menlo Therapeutics, Inc., as Director, The Association of Bioscience Financial Officers, as Director, Phytogen Life Sciences, as Director, Gilead Sciences, Inc., as Chief Financial Officer from 1998 to 2002, InterMune, Inc., as CFO, Senior VP-Finance & Administration from 2002 to 2004, Cytokinetics, Inc., as Chief Financial Officer, Secretary & Executive VP from 2012 to 2017, and Foote, Cone & Belding Healthcare, as Vice President-Strategic Planning.
Ms. Barbari received her undergraduate degree from San Jose State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
0,01% | 14/02/2024 | 1 041 ( 0,01% ) | 3 196 $ | 31/03/2024 |
AGILE THERAPEUTICS, INC.
0,01% | 08/06/2023 | 974 ( 0,01% ) | 331 $ | 31/03/2024 |
Postes actifs de Sharon Barbari
| Sociétés | Poste | Début |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Director/Board Member | 09/06/2020 |
| VYNE THERAPEUTICS INC. | Director/Board Member | 01/03/2020 |
Anciens postes connus de Sharon Barbari
| Sociétés | Poste | Fin |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director/Board Member | 15/09/2021 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Director/Board Member | 01/01/2021 |
| CYTOKINETICS, INCORPORATED | Director of Finance/CFO | 26/06/2017 |
| INTERMUNE INC | Director of Finance/CFO | 01/08/2004 |
| GILEAD SCIENCES, INC. | Director of Finance/CFO | 01/06/2002 |
Formation de Sharon Barbari
| San Jose State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| AGILE THERAPEUTICS, INC. | Health Technology |
| VYNE THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
| Foote, Cone & Belding Healthcare | |
Phytogen Life Sciences
 Phytogen Life Sciences Agricultural Commodities/MillingProcess Industries Phytogen Life Sciences provides cotton production services. The private company is based in Indianapolis, IN. | Process Industries |
